Title of Activity: Generalized Pustular Psoriasis: Through the Eyes of Our Patients

Faculty:
Keisha Cash, DNP, APRN, DCNP, FNP-BC
Steven Feldman, MD, PhD
Dale Reisner

Release Date: 03/05/2025
Expiration Date: 03/05/2026

Target Audience:
This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.

CREDIT INFORMATION
Estimated time for completion: 75 minutes

THERE IS NO FEE FOR THIS ACTIVITY

This activity is awarded 1.25 Nursing Continuing Professional Development/Continuing Education (NCPD/CE) Credits which includes 0.3 Pharmacotherapeutic Contact Hour.

To Receive Credit:

Attend and/or watch the session in its entirety.
Complete/submit the post test and evaluation.
Receive a passing score of 70% or more to receive credit.
Print out your certificate, as well as save it to your computer.

ACCREDITATION STATEMENT:
The Dermatology Nurses’ Association (DNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity is jointly provided by Dermatology Nurses’ Association and
Excalibur Medical Education.

PROGRAM OVERVIEW
Program Purpose: The purpose of this activity is to provide healthcare providers with current information and increased knowledge of the characteristics that distinguish generalized pustular psoriasis (GPP) from other skin conditions; recognize cytokine pathways that play a predominant role in the development and progression of GPP; evaluate strategies that may improve the clinical management of GPP based on results of recent clinical trial and real-world data; select appropriate questions to ask patients diagnosed with GPP; and to uncover quality of life issues that require immediate attention. GPP has a substantial impact on patients’ physical, emotional, and psychological well-being that goes far beyond what many providers see in the clinical setting. It is vital that dermatology advanced practice providers and registered nurses become more aware of some of the most significant issues that impact patients with GPP on a day-to-day basis so that they may help strategize viable solutions.

Learning Objectives
Upon successful completion of this educational program, the participant should be able to:

Review the characteristics that distinguish generalized pustular psoriasis (GPP) from other skin conditions.
Recognize cytokine pathways that play a predominant role in the development and progression of GPP.
List strategies that may improve the clinical management of GPP based on results of recent clinical trial and real-world data.
Describe appropriate questions to ask patients diagnosed with GPP to uncover quality of life issues that require immediate attention.

DISCLOSURE
It is the policy of DNA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by DNA prior to accreditation of the activity.

Planning committee members:
Linda Markham, BSN, RN, DNC, Executive Director & Program Director, Dermatology Nurses’ Association
Audrie Turnow, Managing Partner, Excalibur Medical Education
Trudy Adamson, RN, MSN, DNC, AP-PD
have disclosed that they have no relevant financial relationships or conflicts of interest with ineligible companies related directly or indirectly to this educational activity.

Faculty:
Keischa Cash, DNP, APRN, DCNP, FNP-BC, Steven Feldman, MD, PhD, and Dale Reisner have disclosed that they have no relevant financial relationships or conflicts of interest with ineligible companies related directly or indirectly to this educational activity.

All of the relevant financial relationships listed for these individuals have been mitigated.

COMMERCIAL SUPPORT
Support for this activity has been made possible through an independent educational grant from Boehringer Ingelheim Pharmaceutical, Inc.